Literature DB >> 17481708

Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.

Melody C Carter, Jamie A Robyn, Peter B Bressler, John C Walker, Gail G Shapiro, Dean D Metcalfe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17481708     DOI： 10.1016/j.jaci.2007.03.032

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  33 in total

Review 1.  Understanding the mechanisms of anaphylaxis.

Authors:  Richard D Peavy; Dean D Metcalfe
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-08

Review 2.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 3.  Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

Authors:  A Matito; I Alvarez-Twose; J M Morgado; L Sánchez-Muñoz; A Orfao; L Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

Review 4.  The pathophysiology of anaphylaxis.

Authors:  Laurent L Reber; Joseph D Hernandez; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2017-08       Impact factor: 10.793

Review 5.  [Emergency treatment and management of anaphylaxis].

Authors:  K Brockow; J Ring
Journal:  Hautarzt       Date:  2013-02       Impact factor: 0.751

Review 6.  Mastocytosis: update on pharmacotherapy and future directions.

Authors:  Juan Carlos Cardet; Cem Akin; Min Jung Lee
Journal:  Expert Opin Pharmacother       Date:  2013-10       Impact factor: 3.889

Review 7.  Use of omalizumab in the treatment of food allergy and anaphylaxis.

Authors:  Jay A Lieberman; Mirna Chehade
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

8.  Assessing anaphylactic risk? Consider mast cell clonality.

Authors:  Dean D Metcalfe; Lawrence B Schwartz
Journal:  J Allergy Clin Immunol       Date:  2009-03       Impact factor: 10.793

Review 9.  Immunology and clinical manifestations of non-clonal mast cell activation syndrome.

Authors:  Juan-Carlos Cardet; Mariana C Castells; Matthew J Hamilton
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 10.  Eosinophilia in mast cell disease.

Authors:  Anna Kovalszki; Peter F Weller
Journal:  Immunol Allergy Clin North Am       Date:  2014-03-13       Impact factor: 3.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.